Investor Relations News
November, 2012
Results of Annual General Meeting
Change of Director’s Interest Notice: Washer
Change of Director’s Interest Notice: Dantzker
Change of Director’s Interest Notice: Korten
Change of Director’s Interest Notice: Haghighat
Change of Director’s Interest Notice: MacDonald
October, 2012
ISN ASX Confirm Rights Issue Shortfall
Notice of Annual General Meeting and Explanatory Memorandum
Dispatch of Renounceable Pro-Rate Rights Issue Prospectus
iSonea Files FDA Submission for Over-the-Counter SonoSentry™
September, 2012
Letter to Eligible Shareholders on Rights Issue
Letter to Ineligible Shareholders on Rights Issue
iSonea Announces Fully Underwritten Renounceable Rights Issue to Raise $4M
Appendix 3B: application for quotation of additional securities and agreement
Prospectus: Offer to Eligible Shareholders
August, 2012
Notice of Initial Substantial Holder
Bruce Mathieson Becomes Cornerstone Investor of iSonea
Application for Quotation of Additional Securities and Agreement
Change of Director’s Interest Notice, Washer
Change of Director’s Interest Notice, Haghighat
Change of Director’s Interest Notice, Dantzker
Change of Director’s Interest Notice, Korten
Change of Director’s Interest Notice, Washer
iSonea Completes Capital Consolidation
Isonea run successful App trial in Memphis
iSonea Launches Updated AsthmaSense™ Smartphone App for Global Market
Change of Director’s Interest Notice
July, 2012
iSonea Announces Results of General Meeting
General Meeting Presentation by Micheal Thomas: Value Appreciation Via Sound Asthma Management
iSonea Announces New Chairman of the Board
June, 2012
Updated Capital Consolidation Timetable
OzEquities Analyst Report: Isonea Has Market Leading Asthma Monitoring Products ...
iSonea Launches First Mobile Asthma Technology
April, 2012
Investor Update and Quarterly Report – 31st March 2012
iSonea Announces Changes to Board of Directors
March, 2012
iSonea Launches Pediatric Asthma Study
iSonea Adds Dr. David Dantzker to Board of Directors
iSonea Looks to turn a Smartphone into a Breathing Monitor
iSonea's tech is Covered for Accoustic Monitoring
Cambride Consultants Demos Asthma Training Device
iSonea Issued US Patent for Cough Detector to Diagnose Respiratory Conditions
Dr. Lynn M. Taussig Named Chairman of iSonea’s Medical Advisory Board
February, 2012
iSonea and Qualcomm Life Collaborate on Asthma Mobile Health Technology
CEO Shareholder Update and Q2 FY2012 Results
January, 2012
iSonea to present at Cappello Capital Corp Investor Conference
New Issue Announcement, Application for Quotation of Additional Securities and Agreement
iSonea Limited Commences Trading on the U.S. OTCQX International
iSonea Limited Announces Publication of Initial Viriathus Research Report
December, 2011
iSonea receives Subscriptions under Rights Issue...
Notice of change of interests of substantial holder (RB)
Appendix 3Y: Change of Director’s Interest Notice (RH)
Notice of ceasing to be a substantial holder
Appendix 3Y: Change of Director’s Interest Notice (JK)
Notice Under Section 708A(5) of the Corporations Act
Dispatch of Renounceable Pro-Rata Rights Issue Closure, Acceptances, Shortfall
Michael Thomas, iSonea CEO talks with BRR on launch of new iPhone Application
Rights Issue Prospectus Announcement
Value Appreciation Via Sound Asthma Management - December Presentation 2011
Dispatch of Renounceable Pro-Rata Rights Issue Prospectus
iSonea to Commence Trading in US on OTC Exchange 2 January 2012
Invitation to Investor Luncheons with CEO: Melbourne 5 Dec and Sydney 7 Dec
November, 2011
iSonea Update on Commercialisation of Asthma Management Products
A $4.3M Rights Issue to Accelerate Development Milestone
New issue announcement, application for quotation of additional securities and agreement
Results of 2011 Annual General Meeting
iSonea granted voluntary suspension pending capital raising announcement
iSonea Announces Bank of New York Mellon Appointment
October, 2011
2011 Isonea Annual Financial Report
CEO Mike Thomas Addresses Bergen Institutional
Investment
September, 2011
Letter to Shareholders on Bergen Announcement
iSonea Completes Agreement for $10.6 Million Investment
RB Milestone Group Commences coverage of iSonea Ltd.
August, 2011
iSonea Signs Memorandum of Understanding with Fortune 500 Healthcare Company
Letter to Shareholders: Update
Click for Company stock information
Archive
Date | Headline | |
---|---|---|
Nov. 18 , 2010 |
Karmelsonix wins Frost & Sullivan New Product Innovation Award | View |
Nov. 17 , 2010 |
Karmelsonix highlights the clinical value proposition of its Products | View |
Nov. 11 , 2010 |
Karmelsonix signs agrements with distributors in France, Sweden, Finland, Denmark and Norway | View |
Nov. 9 , 2010 |
Shareholder Update - November 2010 | View |
Oct. 29 , 2010 |
Notice of Annual General Meeting 30th November, 2010 | View |
Oct. 29 , 2010 |
Highlights for the quarter ended 30th September, 2010 | View |
Oct. 28 , 2010 |
Karmelsonix appoints Mr. Bill Nicklin as Manufacturing Consultant | View |
Oct. 20 , 2010 |
Karmelsonix raises Approx. $2 M via issue of convertible notes | View |
Oct. 20 , 2010 |
Karmelsonix announces Board Restructure | View |
Sept. 2, , 2010 |
Proposed Management & Board Restructure | View |
July 19, 2010 |
FDA Grants Clearance for WHolter® Recorder | View |
June 28 , 2010 |
American Medical Association Approves CPT Codes for KSX WheezeRATE and CoughCOUNT Technology | View |
June 22 , 2010 |
KSX WHolter Service - New Revenue Model Launched | View |
June 15 , 2010 |
Karmelsonix Sales & Marketing Update | View |
April 20, 2010 |
Karmelsonix expands its Patent Portfolio in the US | View |
April 15, 2010 |
Karmelsonix signs distribution agreements in the United States | View |
April 8, 2010 |
European CE Mark granted to the company WHolter device | View |
Feb 16, 2010 |
Karmelsonix signs Agreement with second Distributor in India | View |
Feb 16, 2010 |
Key Appointments to Senior Sales & Marketing Team | |
Feb 11, 2010 |
Appointment of New Board Directors | View |
Dec 18, 2009 |
Clinical Study Accepted for Publication in Asthma Journal | View |
Dec 10, 2009 |
KSX Announces Australian Pharmacy Distribution Agreement | View |
Dec 9, 2009 |
Successful Placement of Shares Raises Approx. $4.5m | View |
Dec 3, 2009 |
Karmelsonix secures marketing approval and first substantial order in India | View |
Nov 17, 2009 |
ACCP Applies for WheezeRate CPT Reimbursement Code | View |
Nov 16, 2009 |
Karmelsonix Expands European Distribution Channels | View |
Nov 12 2009 |
Result of Annual General Meeting | View |
Nov 10, 2009 |
Personal Wheezometer® adopted by ALMS Doctors | View |
Oct 13 2009 |
Notice of Annual General Meeting / Proxy Form | View |
Sep 27, 2009 |
Wheezometer® Granted FDA Clearance | View |
Sep 10, 2009 |
Karmelsonix Participation in ERS Congress - Brief Update | View |
Aug 10, 2009 |
Appointment of VP-Sales and Marketing | View |
Jul 30, 2009 |
KSX Technology Update and Commencement of Wheezometer® Sales | View |
Jul 23, 2009 |
Karmelsonix Expands Distribution Channels in Europe | View |
Jul 22, 2009 |
KSX Receives European CE Mark for its Cough Detector | View |
Jul 08, 2009 |
Distribution Agreement Signed with Medi-Point of South Korea | View |
Jun 22, 2009 |
KSX Launches its PulmoTrack Cough Counter Add On Technology | View |
May 28, 2009 |
KSX Receives TGA Approval for its Personal Wheezometer® | View |
May 18, 2009 |
Launch of Personal Wheezometer® at American Thoracic Society | View |
May 11, 2009 |
Grant of new UK Patent to determine airway patency | View |
May 07, 2009 |
First Sale of PulmoTrack into Sleep Laboratory Market | View |
Apr 20, 2009 |
Karmelsonix Receives Further Regulatory Clearance | View |
Apr 7, 2009 |
Karmelsonix award article | View |
Apr 7, 2009 |
Karmelsonix Receives 2009 European Frost and Sullivan Award | View |
Feb 23, 2009 |
Karmelsonix Raises New Capital | View |
Feb 10, 2009 |
ATS accepts KSX Abstracts for presentation at Annual Meeting | View |
Jan 13, 2009 |
Personal Wheezometer® receives regulatory approval in EU | View |
Dec 25, 2008 |
2008 Year-End Update | View |
Nov 17, 2008 |
Directorship | View |
Oct 31, 2008 |
Quarterly Report For The 3 Months Ended 30 September 2008 | View |
Oct 22, 2008 |
Notice of Annual General Meeting | View |
Oct 21, 2008 |
Grant of New Australian Patent | View |
Oct 16, 2008 |
Clinical and Marketing Update | View |
Oct 6, 2008 |
Change of Director’s Interest Notice | View |
Oct 3, 2008 |
New Issue Announcement, Application for Quotation of Additional Securities and Agreement | View |
Oct 2, 2008 |
Annual Financial Report For The Year Ended 30 June 2008 | View |
Sep 16, 2008 |
Notice of change of interests of substantial holder | View |
Sep 16, 2008 |
Change of Director’s Interest Notice | View |
Sep 16, 2008 |
Change of Director’s Interest Notice | View |
Sep 2, 2008 |
Change of Director’s Interest Notice | View |
Sep 2, 2008 |
Change of Director’s Interest Notice | View |
Aug, 29, 2008 |
Karmelsonix Limited, Appendix 4E Preliminary Final Report | View |
Aug 26, 2008 |
Appointment of US Marketing and Sales Director & Appointment of Asia Pacific Marketing Executive Director | View |
Aug 25, 2008 |
New Issue Announcement, Application for Quotation of Additional Securities and Agreement | View |
Aug 25, 2008 |
Karmelsonix Secures Committed Equity Facility Agreement With Trafalgar Capital Specialised Investment Fund For Up To $7.2 Million | View |
Aug 4, 2008 |
Notice of change of interests of substantial holder | View |
Aug 1, 2008 |
New Issue Announcement, Application for Quotation of Additional Securities and Agreement | View |
Jul 31, 2008 |
Quarterly Report for fhe 3 Months Ended 30 June 2008 | View |
Jul 4, 2008 |
Change of Director’s Interest Notice | View |
Jul 4, 2008 |
Change of Director’s Interest Notice | View |
Jul 4, 2008 |
New Issue Announcement, Application for Quotation of Additional Securities and Agreement | View |
Jul 4, 2008 |
Results of Option Exercise Program | View |
Jun 26, 2008 |
PulmoTrack® Sales to Pharmacy Group in Australia Commence | View |
Jun 26, 2008 |
Change of Director’s Interest Notice | View |
Jun 25, 2008 |
Successful Completion of Personal Wheezometer® Engineering Prototype | View |
Jun 22, 2008 |
New Issue Announcement, Application for Quotation of Additional Securities and Agreement | View |
Jun 18, 2008 |
US – Israel Binational R&D Foundation Approves Funding of Joint Venture WIM-GER™ Development | View |
Jun 17, 2008 |
Clinical Study Confirms Utility of Acoustic Transmission Technology in Assessing Asthma | View |
Jun 12, 2008 |
PulmoTrack starts selling in Europe, China, and Taiwan | View |
Jun 3, 2008 |
RM Wise, Research Report Available | View |
Jan 14, 2008 |
RM Reasearch Report | View |